Sunday, June 12, 2011

AstraZeneca - Seroquel - Teen Screen - TMAP - The marketing of disease to our youth/society for greed and profit



AstraZeneca - Seroquel - Teen Screen - TMAP - The marketing of disease to our youth/society for greed and profit


 These are just a couple more glaring examples of how the pharmaceutical industry has highjacked medicine to market drugs including seroquel to the youth of America. Industry backed and funded programs like TeenScreen and TMAP have become the disturbing norm and not the exception.

These Pharmaceutical Corporations are targeting our youth relentlessly all the way from their playpens to college classrooms in an ever expanding scam/con to sell dangerous and negatively life altering drugs in the name of false and corrupted medicine/science for profit.

Corporations have no moral, ethical, or rational basis to market unneeded dangerous drugs to society; except that they are not in the business of health or healing, they are in the business of making money.

The hard truth & bottom line is that until we as a society demand that these mega multinational pharmaceutical corporations be held criminally & financially responsible for the endless stream of targeted assaults upon our citizenry, this monumental problem will continue to manifest itself until virtually no one in America will be left unscathed by these horrific crimes. 

Please Speak Out: let your elected Representatives know that you demand that the pharmaceutical industry and the growing numbers of corrupted doctors supporting their dubious efforts must be held accountable. The lies and profiteering by way of the broken and mangled bodies/minds of our population has to be stopped before this living tragedy turns into a never ending catastrophe.

Hat Tip: Via PharmaGossip Allen Jones speaks 
& 1 Boring Old Man Blog AllenJonesTMAPJanuary20.pdf (application/pdf Object)

I believe by listening and reading Mr. Allen Jones you can begin to get a small glimpse into how ingrained and systemic the disease mongering, corruption, and greed driven schemes really are.




AllenJonesTMAPJanuary20.pdf (application/pdf Object)

The “Model Program” is the Texas Medication Algorithm Project” (TMAP-pronounced TMap)
and it began in Texas in 1995.

TMAP is a Trojan horse embedded with the pharmaceutical industry’s newest and most
expensive mental health drugs. Through TMAP, the drug industry methodically compromised
the decision making of elected and appointed public officials to gain access to captive
populations of mentally ill individuals in prisons and state mental health hospitals.
The pharmaceutical industry bypassed governmental safeguards and medical review by
creating and marketing TMAP as a “treatment model”that was instituted in various states as
an administrative decision by a select few politically appointed officials.

The treatment model accepted by these state officials had a fundamental requirement rooted
deep within it: Doctors must first treat their patients with the newest, most expensive drugs
patented by the pharmaceutical companies. The state doctors treating mental illness could
choose which patented drug to use, but effectively could not choose to use less expensive
generic drugs unless and until the patented drugs failed.

Drug companies marketed their newer, patented medications as safer and more effective than
the older, generic brands. These drugs, they said, not only better treated the symptoms of
mental illness, they did so without the troublesome side-effects often seen with conventional
medications.

However, these new “miracle” drugs did not live up to their hype. They have proven to no
better than generics. Most importantly, most of the new drugs have been found to cause
serious, even fatal side-effects, particularly in children. It is a statistical certainty that many
lives have been lost and many others irreparably damaged.

The drug companies involved in financing and/or directly creating and marketing TMAP
include: Janssen Pharmaceutica, Johnson & Johnson, Eli Lilly, and AstraZeneca
Pfizer, Novartis, Janssen-Ortho-McNeil, GlaxoSmithKline, Abbott, Bristol Myers Squibb,
Wyeth-Ayerst Forrest Laboratories and U.S. Pharmacopeia.

________________________________

Of course if you really want to go the sleaziest marketing route in targeting children: there is this story from Pharmalot in 2008 that will literally send shivers down your spine...

Tiggergate: Using Disney Icons To Sell Seroquel

tiggerHow is this for creative selling? An AstraZeneca regional sales manager allegedly directed the sales reps in her region to use some of Winnie the Pooh’s well-known friends - specifically, Tigger and Eeyore - to promote the Seroquel antipsychotic.
We are told the idea was conveyed at a national sales meeting and on field rides with sales reps, who were told to use Tigger as a bipolar patient and Eeyore - the down-in-the-mouth donkey - as a depressed patient. The reps were allegedly encouraged to use Tigger dolls as giveaways, for instance.
eeyoreWhether any of the reps actually did so is unclear. Nonetheless, an AstraZeneca spokesman tells us that the drugmaker is “investigating the allegations,” although he adds that “it wouldn’t be appropriate to comment further, because it is an open investigation.”
Who knows what lurks in the 100 Acre Woods?

________________________________


For further in-depth reading and professional analysis I would strongly recommend you stop by the 1 Boring Old Man

He has written a must read series of post breaking down TMAP  and various other controversial modern psychiatric and pharmaceutical practices; including a whole series based on the drug Seroquel and atypical anti-psychotics.

seroquel I: introduction to an “atypical”…
seroquel II: phase IIIa…
seroquel II [version 2.0]: guessing…
seroquel III: their best shot…
seroquel IV: ooching…
seroquel V: through the looking glass…
seroquel VI: the fda finale…
seroquel VI: an mid-course interlude…
seroquel VIII: sins of ommission…
seroquel IX: weighty matters…
seroquel X: matters cerebral Serebral…
seroquel XI: through a glass darkly…
seroquel XII: an opinionated postscript…
selling seroquel I: background…
selling seroquel II: into the fray…
selling seroquel III: the data factories…
selling seroquel IV: way off label…
selling seroquel: a mid-winter break…
selling seroquel V: driving the brand…
selling seroquel VI: claims…
selling seroquel VII: indication sprawl…
selling seroquel VIII: CRO-Charts…
contents of an empty mind……
the clinical research industry: time-to-market and beyond…
the clinical research industry: the CRCs…
we interrupt this program for… gulp…
the clinical research industry: the cro running in the background…
the clinical research industry: an invisible empire…
the clinical reasearch industry: the ‘atypical’ decade…
patent medicines…
Seroquel XR: an extended release…
supercharged placebos…
atypical augmentation: statistical but irrelevant…
Zyprexa: the early earliest years…
Zyprexa: the other early years…
Zyprexa: incitement to malpractice…
Zyprexa: hyperglycemia and diabetes…
Zyprexa: so what’s wrong with Martha?…
Zyprexa: making history…

No comments:

Post a Comment

Please be civil, agree to disagree, and express your opinion. Comments will be moderated for content to avoid inflammatory language and spam